<div>Hello everyone,
</div>
<div><br />
</div>
<div>We have set up this page to help enable our incredible brother, Paul, to access the medical treatment he so desperately needs to turn the tide in his battle against Stage 4 (metastatic) bowel cancer.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648018632535_r." width="100%" />
<div><br />
</div>
<div>If anyone deserves a second chance to live, it's Paul. In 2018, he was widowed at the age of 36, having lost his first wife to breast cancer.
</div>
<div><br />
</div>
<div>After starting to rebuild his life, and falling in love with Rachel in 2019, just one year later, Paul himself was diagnosed with Stage 4 bowel cancer, despite being completely asymptomatic.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648064598256_r." width="100%" />
<div><br />
</div>
<div>Since then, he has shown tremendous grit, determination, and courage in battling his way through major surgeries and chemotherapy, getting to a place where he had no evidence of any ongoing disease and with the hope that treatment had been curative.
</div>
<div><br />
</div>
<div>Paul and Rachel married in April 2022, and within weeks they were overjoyed to find out they were expecting a baby. It's almost unbelievable that the very next day, their world shattered once again when Paul was informed that his cancer had returned.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648100981034_r." width="100%" />
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648130915192_r." width="100%" />
<div><br />
</div>
<div>Following this relapse, there are now no further curative treatments available in the UK.
</div>
<div><br />
</div>
<div>No NHS treatments can now enable Paul - a new daddy to our 11-week-old nephew and an adored step-daddy to Reuben and Eden (5 and 8 years old) - to live and watch his young family grow up.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648162330286_r." width="100%" />
<div><br />
</div>
<div><strong>But there is still hope.</strong>
</div>
<div><br />
</div>
<div>Paul's prognosis will radically change if we can help him access new life-changing treatments, immunotherapy, targeted drugs and trials that are only available in the US. Accessing medical care outside of the UK, however, requires substantial funds.
</div>
<div><br />
</div>
<div>Therefore, Paul and his family would be forever grateful for anything that you can give and for sharing this fundraiser as widely as possible with your family, friends and through your networks.
</div>
<div><br />
</div>
<div>The Cancer Charity MacMillan works by this simple but powerful statement: "So whatever cancer throws your way, we're right there with you". That is our commitment to Paul and Rachel.
</div>
<div><br />
</div>
<div>So thank you for standing with us as we fight for Paul and his family and take our stand against cancer.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648236753936_r." width="100%" />
<div><br />
</div>
<div>Your generosity and support are greatly appreciated and could help spare this young family from further tragedy.
</div>
<div><br />
</div>
<div>Rachel, Paul's wife, has shared a more detailed and personal reflection of the journey they have been on together below.
</div>
<div><br />
</div>
<div>With our thanks, the Garratt brothers,
</div>
<div><br />
</div>
<div>Neil, Mark and Jamie Garratt
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648271298510_r." width="100%" />
<div><br />
</div>
<div>________
</div>
<div><br />
</div>
<div><strong>My amazing husband's cancer journey - Dr Rachel Garratt (NHS GP)</strong>
</div>
<div><br />
</div>
<div>In October 2020, just days after his 39th birthday, and having only just recovered emotionally and psychologically from losing his first wife to breast cancer, Paul was given the shocking diagnosis of metastatic bowel cancer. After curative surgeries to remove his ascending colon and part of his liver, Paul then endured almost a year of chemotherapy.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648322172804_r." width="100%" />
<div><br />
</div>
<div>Those of you who know Paul will understand just how positive and determined he is. After changing his diet and beginning a strict exercise regime, he made a full recovery, becoming fitter and stronger than ever before, returning to full-time work in the charity sector and playing tennis for his local tennis club! By September 2021, Paul had responded so well to treatment that we dared to believe we had beaten cancer.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648351419167_r." width="100%" />
<div><br />
</div>
<div>In April 2022, on what was an incredible day, Paul and I got married. Shortly afterwards, we found out that I was pregnant with our longed-for child, and that Paul was going to become a father. We believe this was a miracle given the amount of toxicity his body had been exposed to and my own previous fertility journey.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648389232903_r." width="100%" />
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_168164841560660_r." width="100%" />
<div><br />
</div>
<div>Sadly, just the very next day, in one of life's cruel twists, Paul's Oncologist broke the devastating news to us, that cancer had returned to his lungs and pelvis, swiftly moving him into the 'incurable' camp. Words can't begin to convey how hard this news hit us.
</div>
<div><br />
</div>
<div>At a time when we should have been celebrating the prospect of a new baby, I was filled with grief at the prospect of losing my husband and our unborn child's Daddy.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648451798213_r." width="100%" />
<div><br />
</div>
<div>So we set out with fresh resolve to do everything we could, managing to access state-of-the-art treatments at both UCLH and The Royal Brompton Hospital in London. Despite subsequent clear scans in late 2022, just after our son Elias was born in January this year, we were again told that cancer had returned to his lungs.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648472569336_r." width="100%" />
<div><br />
</div>
<div>Paul's cancer has a specific genetic mutation (KRAS G12-D). This means that the only treatments now available to him on the NHS are over 40 years old (standard chemotherapies) and can only extend his life by a small margin - certainly not long enough for him to take Elias for his first day at school.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648493611574_r." width="100%" />
<div><br />
</div>
<div>As you can imagine, we have been desperate to find hope in what has felt like a hopeless situation. After extensively researching our options and discussing these with oncologists both in the UK and the USA, we have learned that MD Anderson Hospital in Houston, and Memorial Sloan Kettering Cancer Center in New York, both offer a range of immunotherapies, targeted treatments and trials for Paul's specific type of cancer mutation. These are not available, even privately, in the UK and will likely take many years to arrive and be approved for NHS funding; time we, unfortunately, do not have.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648515186318_r." width="100%" />
<div><br />
</div>
<div>MD Anderson and Memorial Sloan Kettering are leading cancer centres, providing patients with new therapies years before they become standard in other hospitals. Many of those who have received these proven treatments have had nothing short of a miraculous response. Furthermore, MD Anderson is the first hospital in the world to trial a targeted therapy that specifically locates and attacks the KRAS G12-D mutation. Although no one in the cancer world talks about a cure (yet!), those treating Paul believe that it is very realistic that with the right immunotherapy and targeted therapy, Paul could be able to manage cancer like a chronic illness.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648535374431_r." width="100%" />
<div><br />
</div>
<div>So for us, the choice is stark.
</div>
<div><br />
</div>
<div>We could just continue with the standard NHS treatment, which may give Paul a few more years of life.
</div>
<div><br />
</div>
<div>Or we could do everything possible to access the bespoke drugs and trials in America, offering the hope that Paul can live many more full and fruitful years with us as a family.
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648562694179_r." width="100%" />
<div><br />
</div>
<div>Until we have our first clinic appointment with Memorial Sloan Kettering in May, we are yet to know the full extent of the total costs. However, in the immediate term, Paul's oncologist here in the UK has recommended that we self-fund the drug Bevacizumab (Avastin) which he will start next week. This is a targeted treatment that costs approximately £2,000 per dose and is given on a 2-weekly basis, in addition to Paul starting back on standard chemotherapy.
</div>
<div><br />
</div>
<div>Avastin is provided as standard care in the USA and many other countries, but is still not funded by the NHS, despite extensive campaigning and clear evidence for its effectiveness. Following Paul's initial assessment at Memorial Sloan Kettering, we will then use funds raised to cover the associated costs to access the most suitable treatment plan suggested for Paul. Based on a trusted US oncologist's advice, we have set a financial target of £200,000 to cover the above costs, enabling us to pursue this.
</div>
<div><br />
</div>
<div>Although raising this amount seems like a massive challenge, as Paul's wife and mummy to Elias, no price can be placed on the precious years ahead that we will be able to enjoy together as a result of your generosity.
</div>
<div><br />
</div>
<div>Thank you,
</div>
<div><br />
</div>
<div>Dr Rachel Garratt
</div>
<div><br />
</div><img class="m-text-editor-image" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/72328173_1681648646257858_r." width="100%" />
<div><br />
</div>

Maria Kearns

Anonymous

William Mccorkell

Kieran Cornwell

Jeremy Tagg

Paul Boshier

Ian Nicoll

Emma Mccorkell

James Khoo

Jeni Summerfield

John Broady

Sean and Lorna Tully

Help Paul access life-saving cancer treatments

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Help Paul access life-saving cancer treatments

Still £177,664 to go. Help us build momentum.